MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy

https://doi.org/10.1016/j.nmd.2007.01.010Get rights and content

Abstract

In order to characterize, at the clinical, molecular and imaging level, myopathies due to MYH7 gene mutations, MYH7 gene analysis was conducted by RT-PCR/SSCP/sequencing in two patients diagnosed with myosin storage myopathy and 17 patients diagnosed with scapulo-peroneal myopathy of unknown etiology. MYH7 gene studies revealed the 5533C > T mutation (Arg1845Trp) in both myosin storage myopathy and in 2 of the 17 scapulo-peroneal patients studied. 5533C > T segregation analysis in the mutation carrier families identified 11 additional patients. The clinical spectrum in our cohort of patients included asymptomatic hyperCKemia, scapulo-peroneal myopathy and proximal and distal myopathy with muscle hypertrophy. Muscle MRI identified a unique pattern in the posterior compartment of the thigh, characterized by early involvement of the biceps femoris and semimembranosus, with relative sparing of the semitendinosus. Muscle biopsy revealed hyaline bodies in only half of biopsied patients (2/4). In conclusion, phenotypic and histopathological variability may underlie MYH7 gene mutation and the absence of hyaline bodies in muscle biopsies does not rule out MYH7 gene mutations.

Introduction

Myosin storage myopathy is a rare congenital myopathy characterized by slowly progressive muscle weakness and by the presence in muscle biopsy of subsarcolemmal eosinophilic formations called hyaline bodies (HB) in slow, oxidative (type I) fibers [1]. Similar pathological findings have also been reported earlier under different names [2], [3]. Recently Oldfords proposed the name of myosin storage myopathy for this entity, based on the findings in HBs of large inclusions consisting of slow heavy chain myosin (MyHC I) and on the identification of causative mutations in the MYH7 gene coding for MyHC I [4]. Subsequently, mutations in the MYH7 gene have been reported in a Saudi Arabian family [5], [6], in two isolated cases [7] and in one of the cases originally reported by Cancilla et al. [2], [8]. Interestingly, myosin storage myopathy is allelic to Laing early-onset distal myopathy (MPD1), clinically characterized by early onset and by selective weakness of the anterior tibial muscles followed by weakness of finger extensors [9], and to a common form of hypertrophic or dilated cardiomyopathy [10].

Clinical presentation in myosin storage myopathy includes hypotonia and delayed motor milestones [2], non-progressive weakness [1], [3], [6], [7], rapidly progressive muscle weakness with loss of ambulation and marked loss of subcutaneous fat [6], scapulo-peroneal muscular dystrophy [11], and slowly progressive muscle weakness, with winging of the scapulae and with or without pseudohypertrophy of the calves [4], [7]. Despite these various clinical presentations, muscle histopathology is uniform and is characterized by the presence of HBs in type I muscle fibers. HBs lack activity for glycogen and oxidative enzymes but retain reactivity for myofibrillar ATPase and ultrastructurally consist of granular or slightly filamentous storage material in the muscle fiber inclusion [1], [2], [3], [4], [5]. HBs positively immunostain for MyHC I [4], [5]. The mechanisms of formation of HBs and the functional consequences of myosin storage in muscle are not well understood, however it is likely that myosin storage myopathy may be caused by a defective assembly of the thick filaments [4]. Interestingly, the only three causative MYH7 gene mutations reported in myosin storage myopathy, L1793P [8], R1845W [4], [7], and H1901L [6], reside in the distal rod region of the myosin molecule involved with the interaction with other myosin molecules or with other proteins essential for alignment of the thick filaments [12].

Here we report clinical, muscle magnetic resonance imaging (MRI), and histopathological findings in patients with the MYH7 gene mutation.

Section snippets

Patients

About 6000 consecutive muscle biopsies from our Institution’s tissue bank were screened for patients who met the following clinical and/or histopathological criteria:

  • muscle histopathology showing HBs in type I muscle fibers;

  • muscle histopathology showing mixed myopathic and neurogenic changes and clinical phenotype consistent with a scapulo-peroneal myopathy.

Seventeen patients with scapulo-peroneal myopathy of unknown etiology and two patients showing HBs in their muscle biopsies were selected

Family A

This study was prompted by the clinical observation of patient II-12 (Fig. 1, Fig. 2 and Table 1). Individual II-12 was a 66-year-old man who presented with a history of progressive weakness since childhood. His early motor milestones were slightly retarded and he had always been clumsy. At 62 years he had difficulty climbing stairs, rising from a chair, and lifting weight with his upper limbs. Neurological examination showed a waddling gait with marked paresis on feet dorsiflexion (footdrop),

Discussion

The gene encoding the slow skeletal muscle fibers myosin heavy chain gene is mutated in myosin storage myopathy [4]. Mutations in the same gene also underlie Laing early onset distal myopathy (MPD1) [9] and a common form of both dilated and hypertrophic cardiomyopathy [10]. The clinical phenotype of myosin storage myopathy is quite heterogeneous, and variable age at onset, disease progression rate and severity have been reported [1], [2], [3], [4], [6], [7]. In spite of clinical heterogeneity,

Acknowledgements

Supported by grants from the Italian Telethon (# GTF02009) and EuroBioBank.

The corresponding author has full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

References (17)

There are more references available in the full text version of this article.

Cited by (45)

  • MYH7-related disorders in two Bulgarian families: Novel variants in the same region associated with different clinical manifestation and disease penetrance

    2021, Neuromuscular Disorders
    Citation Excerpt :

    One of them most probably affects the assembly competence domain, part of LMM, which is responsible for the filament formation [20,21]. In the first family the novel MYH7 variant c.5746C>T was identified in individuals with a broad variability of the phenotype, which has been described in previous reports [17,22,23]. Dilated cardiomyopathy is the common feature in both affected members with pronounced anticipation, as the child died due to heart failure at the age of 2 years and 4 months while the father passed away in his fourth decade.

  • POPDC2 a novel susceptibility gene for conduction disorders

    2020, Journal of Molecular and Cellular Cardiology
  • Mutations in MYH7 cause Multi-minicore Disease (MmD) with variable cardiac involvement

    2012, Neuromuscular Disorders
    Citation Excerpt :

    Lastly, it has been suggested that mutations concerning the distal rod domain of the beta myosin heavy chain may be associated with a wider clinico-pathological spectrum [24]. The muscle MR imaging findings in the index case in Family 1 confirmed the previous report of predominant distal lower limb involvement and the predominant hamstring involvement within the thigh, although the previously reported selective semitendinosus sparing was not observed [21]. Interestingly, the marked soleus involvement observed in our patient corresponds to the high level of beta myosin heavy chain expression documented in this muscle [47].

View all citing articles on Scopus
View full text